ResearcherYale UniversityNo recent work listed

Timil H. Patel

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5067438387. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System. Co-author DOI 10.21037/jgo-21-202 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Stacey Stein · 1 shared paper, 2021 · strength 0.14
- Paper Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Y… DOI 10.21037/jgo-21-202 ↗
Michael Cecchini · 1 shared paper, 2021 · strength 0.14
- Paper Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Y… DOI 10.21037/jgo-21-202 ↗
Jill Lacy · 1 shared paper, 2021 · strength 0.14
- Paper Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Y… DOI 10.21037/jgo-21-202 ↗
Kimberly L. Johung · 1 shared paper, 2021 · strength 0.14
- Paper Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Y… DOI 10.21037/jgo-21-202 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.